1. Effects of IL‐1β–Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms. (11th June 2014) Authors: Palmér, R; Nyman, E; Penney, M; Marley, A; Cedersund, G; Agoram, B Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 6(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluating Systems Pharmacology Models Is Different From Evaluating Standard Pharmacokinetic–Pharmacodynamic Models. (19th February 2014) Authors: Agoram, B Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 2(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation. (11th July 2017) Authors: Ribba, B; Grimm, HP; Agoram, B; Davies, MR; Gadkar, K; Niederer, S; van Riel, N; Timmis, J; van der Graaf, PH Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 8(2017) Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗